Roivant Dives Deeper into AI with $450 Million Buy of Silicon Therapeutics
The Silicon Therapeutics acquisition is designed to complement Roivant’s targeted protein degradation platform.
The Home of the Life Sciences Industry
Explore Latest News
FDA Approves Third Sarepta Treatment For Duchenne Muscular Dystrophy
The U.S. FDA approved Sarepta Therapeutics’ Amondys 45 (casimersen) for patients with Duchenne muscular dystrophy (DMD) who have a confirmed mutation amenable to exon 45 skipping.
- Perceptive Advisors’ ARYA Sciences Acquisition IV Raises $130 Million in IPO
- BioSpace Movers & Shakers, Feb. 26
- Research Roundup: Compound Reverses ALS Nerve Damage and More
- Field Trip Health’s New Psilocybin Research Facility Probes the Secrets of Shrooms
- Merck Snaps Up Autoimmune-Focused Pandion in Massive $1.85 Billion Deal
Get personalized job alerts
Create a job alert and receive custom job recommendations straight to your inbox.
Employers
Post jobs on BioSpace and start building your talent pipeline today. Click the button to access our easy eCommerce site, which lets you purchase and post jobs in just a few clicks.